Behandlung von Herzklappenerkrankungen ohne operativen Eingriff : Innovatives Forschungs- und Entwicklungsprojekt
Einer der wesentlichen Bereiche der Medizin, in der die Entwicklungen in der Medizintechnik eine herausragende Rolle spielen, ist die Kardiologie. Trotz der Fortschritte sind bis heute ganze Krankheitsbilder nicht oder nur unzureichend minimalinvasiv behandelbar. Umso wichtiger ist es, in diesem Bereich zu forschen.
Mitral regurgitation is one of the
leading causes of valve malfunction
in humans. Based on demographic
changes such as increased life
expectancy, the rate of valvular
diseases is set to increase in the
coming decades. Currently, surgical
procedures are the gold standard for
the treatment of valvular diseases;
however, innovative, efficient and
minimally invasive techniques are
also needed to cure inoperable patients.
The current project includes a
patent to address mitral regurgitation
with a minimally invasive device
and this article describes the process
from the idea stage to the full protection
of the intellectual property (IP). In particular it focuses on the
sector within the university structure
which deals with the protection of
the IP, enabling the transition from
a research project to a clinical device,
which can be used to help people
with this common cardiovascular
malfunction. The project has been
awarded first prize in the competition
„ZukunftErfindenNRW“
(“Inventing the Future, North Rhine
Westphalia”).
Vorschau
